Company Filing History:
Years Active: 2009
Title: Sunhee Kang - Innovator in Pharmaceutical Chemistry
Introduction
Sunhee Kang is an accomplished inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target specific receptors in the central nervous system.
Latest Patents
Her notable patent, titled “3-aryl-3-methyl-quinoline-2,4-diones, preparation method thereof, and pharmaceutical composition containing the same,” showcases her innovative work. This invention relates to compounds acting as a 5HT6 receptor antagonist and includes a preparation method for these compounds. The pharmaceutical composition developed from her research is particularly promising for the treatment of central nervous system disorders. The compounds exhibit excellent binding affinity for the 5HT6 receptor, making them a valuable asset in addressing disorders associated with this receptor.
Career Highlights
Sunhee Kang is affiliated with the Korea Research Institute of Chemical Technology, where she has been instrumental in advancing research in chemical technology. Her career reflects a strong commitment to innovation and her work has earned her recognition within the scientific community.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues, including Churlmin Seong and Nosang Park. These partnerships have likely contributed to the advancement of her research and the successful development of her patented inventions.
Conclusion
In summary, Sunhee Kang stands out as a notable inventor in the pharmaceutical field, with a focus on compounds that can significantly impact the treatment of central nervous system disorders. Her dedication to research and innovation continues to drive progress in pharmaceutical chemistry, making her a valuable contributor to the scientific community.